Question:
A patient with Stage I NSGCT has persistently elevated HCG and AFP after orchiectomy. What is the next step?
A patient with Stage I NSGCT has persistently elevated HCG and AFP after orchiectomy. What is the next step?
Show Hint
Staging rule: Elevated markers after orchiectomy + Normal CT scans = Stage IS.
The treatment for Stage IS Testicular Cancer (NSGCT or Seminoma) is ALWAYS primary Chemotherapy, never surgery or surveillance.
The treatment for Stage IS Testicular Cancer (NSGCT or Seminoma) is ALWAYS primary Chemotherapy, never surgery or surveillance.
Updated On: Sep 3, 2026
- Chemotherapy
- Modified nerve-sparing RPLND
- Radiotherapy
- Surveillance
Show Solution
Verified By Collegedunia
The Correct Option is A
Solution and Explanation
Concept:
The management of testicular cancer relies heavily on the behavior of tumor markers following radical orchiectomy. Persistently elevated markers define a specific clinical stage that requires systemic intervention.
Explanation:
• A patient initially diagnosed with Clinical Stage I Non-Seminomatous Germ Cell Tumor (NSGCT) has disease supposedly confined to the testicle, with normal CT scans of the chest, abdomen, and pelvis.
• After the primary tumor is removed via orchiectomy, the serum tumor markers (HCG and AFP) are expected to decline and normalize according to their respective half-lives.
• If the markers plateau or remain persistently elevated despite normal imaging, the patient is reclassified as having Clinical Stage IS (marker-only disease).
• Persistently elevated markers constitute undeniable biochemical evidence that the patient harbors active, occult systemic micrometastases.
• Because the disease is systemic, placing the patient on surveillance (Option D) is contraindicated, as the cancer is already known to be active.
• Radiotherapy (Option C) is generally ineffective for NSGCT and is not part of its standard algorithm.
• While Retroperitoneal Lymph Node Dissection (RPLND) (Option B) is an option for certain high-risk Stage I patients with normal markers, Stage IS implies systemic spread that may exist outside the retroperitoneal template.
• Therefore, the standard of care and definitive next step for Clinical Stage IS NSGCT is systemic induction chemotherapy, typically consisting of 3 cycles of BEP (Bleomycin, Etoposide, Cisplatin) or 4 cycles of EP.
Final Answer:
Persistently elevated markers indicate Stage IS systemic micrometastatic disease, necessitating primary systemic chemotherapy.
The management of testicular cancer relies heavily on the behavior of tumor markers following radical orchiectomy. Persistently elevated markers define a specific clinical stage that requires systemic intervention.
Explanation:
• A patient initially diagnosed with Clinical Stage I Non-Seminomatous Germ Cell Tumor (NSGCT) has disease supposedly confined to the testicle, with normal CT scans of the chest, abdomen, and pelvis.
• After the primary tumor is removed via orchiectomy, the serum tumor markers (HCG and AFP) are expected to decline and normalize according to their respective half-lives.
• If the markers plateau or remain persistently elevated despite normal imaging, the patient is reclassified as having Clinical Stage IS (marker-only disease).
• Persistently elevated markers constitute undeniable biochemical evidence that the patient harbors active, occult systemic micrometastases.
• Because the disease is systemic, placing the patient on surveillance (Option D) is contraindicated, as the cancer is already known to be active.
• Radiotherapy (Option C) is generally ineffective for NSGCT and is not part of its standard algorithm.
• While Retroperitoneal Lymph Node Dissection (RPLND) (Option B) is an option for certain high-risk Stage I patients with normal markers, Stage IS implies systemic spread that may exist outside the retroperitoneal template.
• Therefore, the standard of care and definitive next step for Clinical Stage IS NSGCT is systemic induction chemotherapy, typically consisting of 3 cycles of BEP (Bleomycin, Etoposide, Cisplatin) or 4 cycles of EP.
Final Answer:
Persistently elevated markers indicate Stage IS systemic micrometastatic disease, necessitating primary systemic chemotherapy.
Was this answer helpful?
0
0
Top NEET SS Surgical Questions
- A post-mastectomy patient (for malignant breast lump) who also had axillary lymph node dissection now presents in the postoperative period (after drain removal) with a soft, fluctuant swelling in the axilla extending into the mastectomy site.
- A patient presents with a large, multilobulated breast tumour clinically suggestive of phyllodes tumour, and there is a significant family history of breast cancer (grandmother) and prostate cancer (father). What is the next step in management?
- In a young woman with a breast lump confirmed on ultrasound to be a simple cyst, what is the next step in management?
- A 45-year-old woman underwent investigations for a breast lump. Her biopsy report confirms invasive ductal carcinoma of the breast. You are the surgical resident in charge and need to communicate the diagnosis to her. What is the most appropriate approach?
- A 35-year-old woman, a chronic smoker, presents with recurrent painful periareolar swelling and purulent nipple discharge for the past 6 months. She has undergone incision and drainage twice, but the symptoms recur after a short period. Which of the following statements about the most likely diagnosis is true?
View More Questions
Top NEET SS Genitourinary Surgery Questions
- Which of the following is not a prognostic factor in renal cell carcinoma (RCC)?
- A patient with a testicular tumor presents with raised HCG and AFP. What is the most probable diagnosis?
- In carcinoma penis, when is dynamic sentinel lymph node biopsy (SLNB) indicated?
- Which of the following is an indication for performing a renal biopsy in RCC?
- In a patient with a testicular tumor, which of the following statements is true regarding tumor markers?
View More Questions
Top NEET SS Questions
- A liver transplant patient presents with diarrhoea, colitis, a total leukocyte count of 1800, and a positive blood CMV PCR. What is the next step in management?
- A 32-year-old male recovering from dengue fever initially showed clinical improvement but now presents with recurrence of high-grade fever, fatigue, and pancytopenia on day 10 of illness. He is hemodynamically stable with no bleeding manifestations. Which of the following investigations should be performed first to evaluate the cause of relapse and cytopenia?
- A 48-year-old man with chronic hepatitis C infection is being evaluated for risk factors associated with progression of liver disease. He has a 20-year history of infection, drinks alcohol occasionally, and has a high serum HCV RNA viral load. Which of the following factors is not associated with an increased risk of progression of liver disease in chronic HCV infection?
- A 28-year-old veterinary worker who previously received a full 3-dose pre-exposure rabies vaccination series is bitten by a stray dog while handling an animal in the clinic. The wound is cleaned immediately. What is the most appropriate post-exposure management?
- A 42-year-old patient undergoing chemotherapy for acute myeloid leukemia develops neutropenia (ANC $<$ 500) and is treated with broad-spectrum antibiotics. After initial recovery of neutrophil counts (ANC = 1500), he again develops high-grade fever and right upper quadrant abdominal pain. Imaging shows multiple small hypodense lesions in the liver and spleen. What is the most likely diagnosis?
View More Questions